Professor Leon Terstappen, Professor of Medical Cell Biophysics at the University of Twente, who leads the international project, added: "We want to find out more about 'that one cell' that is left behind and that suddenly becomes active years after the primary tumour was treated.
The academic leads of the CANCER-ID consortium are Prof. Klaus Pantel, Head of the Department of Tumor Biology at the University Medical Center Hamburg-Eppendorf, Germany, and Prof. Leon Terstappen, Head of the Department of Medical Cell Biophysics at the University of Twente, The Netherlands.
Leon Terstappen, chief scientific officer of Immunicon commented, "The new FDA-cleared claims in metastatic colorectal cancer are very important because the clinical utility of CTC counts is validated in a second major carcinoma.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.